Dr. Peter Chin, a renowned neurologist and Principal Medical Director of Global Neuroscience Development at Genentech, a member of the Roche Group, participated in an exclusive interview with Multiple Sclerosis News Today correspondent Dr. Ana de Barros on the company’s promising multiple sclerosis (MS) therapy ocrelizumab.
Read the article: http://bit.ly/1JZddMJ
What medicine can secondary progressive ms use to slow down progression
I have aggressive PPMS
Time is of the essence! Four years ago I knew of nothing wrong, today I can barely walk and have the energy of someone with the flu.There are four questions in life each one of us must ask. Origin, meaning, morality, destiny. Where do I come from? What gives life meaning? How do I separate right from wrong? What is the end of all of this? When you are looking for truth you must make sure that each one of these questions are answered.